Cancer Immunotherapy

Cancer immunotherapy is the use of the immune system to treat cancer. Immunotherapies can be broadly categorized into active, passive or hybrid (active and passive). These techniques exploit the fact that cancer cells often have molecules on their surface that can be identified by the immune system, known as tumour-associated antigens (TAAs); they are often proteins or other macromolecules (e.g. carbohydrates). Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment

  • Monoclonal antibodies
  • Immune checkpoint inhibitors
  • Cancer vaccines

Related Conference of Cancer Immunotherapy

November 26-27, 2018

3rd International Conference on Autoimmunity

Dublin, Ireland (Louis Fitzgerald Hotel)
December 05-06, 2018 | Lisbon, Portugal

Global Meet on Immunology, Hematology & Molecular Biology

Holiday Inn Lisbon, Portugal
December 06-07, 2018

Annual Congress on Antibiotics and Antimicrobial Resistance

Amsterdam, Netherlands
February 22-23, 2019

World Congress on Immunity and Immuno Therapies

Dallas, Texas, USA
March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
March 18-19, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 24-25, 2019

11th World Congress and Expo on Immunology

Vancouver, Canada
October 21-22, 2019

12th Annual Congress on Immunology & Immunogenetics

Rome, Italy
November 22-23, 2019 |

World Conference on Vaccine and Immunology

Dubai, UAE

Cancer Immunotherapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in